To further test if GSDME possesses a tumor suppressive activity in vivo, we utilized a mouse model of melanoma whereby WT C57BL/6J were subcutaneously injected with either WT or GSDME-KO B16-Ova melanoma cells and tumor growth was monitored over time. This evidence concerns the gene GSDME and melanoma.